スポンサーリンク
東京大学医科学研究所ヒトゲノム解析センター | 論文
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Kawasaki Disease in Mongolia : Results From 2 Nationwide Retrospective Surveys, 1996-2008
- 生命パスウェイの脆弱部位推定の一考察
- Cell Illustratorにおける視覚化支援ツールの開発と検討
- GONとSBMLにおけるXMLパスウェイ形式の対応
- Relationship between the Cumulative Incidence of Kawasaki Disease and the Prevalence of Electrocardiographic Abnormalities in Birth-Year Cohorts
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- 本邦 von Hippel-Lindau 病に伴う褐色細胞腫の特徴 : 全国疫学調査とその解析結果
- von Hippel-Lindau 病全国疫学調査における腎癌の臨床的解析
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- 1SK-04 スパコンで焙り出すがんのシステム(1SK 高速計算機シミュレーションによる生体機能解析へのアプローチ,日本生物物理学会第49回年会(2011年度))
- Malignant transformation of breast fibroadenoma to malignant phyllodes tumor : long-term outcome of 36 malignant phyllodes tumors
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Genetic differences in the two main groups of the Japanese population based on autosomal SNPs and haplotypes
- Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography